A share price of Teladoc Health Inc [TDOC] is currently trading at $7.57, down -5.37%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TDOC shares have gain 8.14% over the last week, with a monthly amount drifted -0.26%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Teladoc Health Inc [NYSE: TDOC] stock has seen the most recent analyst activity on December 09, 2025, when Barclays initiated its Equal Weight rating and assigned the stock a price target of $8.50. Previously, BMO Capital Markets started tracking the stock with Market Perform rating on November 13, 2025, and set its price target to $8. On July 25, 2025, Mizuho initiated with a Neutral rating and assigned a price target of $10 on the stock. Goldman started tracking the stock assigning a Buy rating and suggested a price target of $14 on November 15, 2024. Jefferies reiterated its recommendation of a Hold and raised its price target to $10 on September 17, 2024. Cantor Fitzgerald started tracking with an Overweight rating for this stock on February 29, 2024, and assigned it a price target of $22. In a note dated February 26, 2024, Leerink Partners initiated a Market Perform rating and provided a target price of $17 on this stock.
Teladoc Health Inc experienced fluctuations in its stock price throughout the past year between $6.35 and $15.21. Currently, Wall Street analysts expect the stock to reach $8.83 within the next 12 months. Teladoc Health Inc [NYSE: TDOC] shares were valued at $7.57 at the most recent close of the market. An investor can expect a potential return of 16.64% based on the average TDOC price forecast.
Analyzing the TDOC fundamentals
Trailing Twelve Months sales for Teladoc Health Inc [NYSE:TDOC] were 2.53B which represents -2.20% decline. Gross Profit Margin for this corporation currently stands at 0.7% with Operating Profit Margin at -0.11%, Pretax Profit Margin comes in at -0.1%, and Net Profit Margin reading is -0.09%. To continue investigating profitability, this company’s Return on Assets is posted at -0.08, Equity is -0.16 and Total Capital is -0.11. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.75.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.38 points at the first support level, and at 7.19 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.91, and for the 2nd resistance point, it is at 8.24.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Teladoc Health Inc [NYSE:TDOC] is 2.61. As well, the Quick Ratio is 2.52, while the Cash Ratio is 1.79. Considering the valuation of this stock, the price to sales ratio is 0.53, the price to book ratio is 0.96.
Transactions by insiders
Recent insider trading involved Catapano Joseph Ronald, Chief Accounting Officer, that happened on Jan 05 ’26 when 758.0 shares were sold. CHIEF EXECUTIVE OFFICER, DIVITA CHARLES III completed a deal on Dec 11 ’25 to sell 17138.0 shares. Meanwhile, Officer DIVITA CHARLES III bought 17138.0 shares on Dec 11 ’25.
